An experimental and clinical study of ayurvedic drug compound pandughni vati on Iron Deficiency Anemia in children

A PHARMACO-CLINICAL STUDY OF PANDUGHNI VATI ON PANDU (IRON DEFICIENCY ANEMIA) IN CHILDREN - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/12/002310

Enrollment

Registered

2011-12-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency Health Condition 2: null- Pandu (Iron Deficiency Anemia)

Interventions

Intervention1: Pandughni Vati : dose is decided according to guideline of Sarngdhara i.e 3, 6.5 and 10.5 gms per day for the age group of 2 to 6, 7 to 11 and 12 to 16 years respectively in three div

Eligibility

Inclusion criteria

Inclusion criteria: patients presenting with signs and symptoms of Pandu (IDA)having Hb% less than 11.5 g% and microcytic hypochromic anemia in peripheral smear

Exclusion criteria

Exclusion criteria: patients with hemoglobinopathies, bleeding disorders, malignancy, and other systemic diseases such as Tuberculosis, Juvinile diabetes mellitus etc Also patients having Hb% less than 6.5 g%

Design outcomes

Primary

Measure	Time frame
Improvement in clinical signs and symptoms, Changes in Hb% and peripheral smear findingsTimepoint: assessed after 90 days of treatment	—

Secondary

Measure	Time frame
Improvement in quality of life parametresTimepoint: assessed after 90 days of treatment	—

Countries

India

Contacts

Public ContactDr Kalpana S Patel

Institute of post graduate teaching and research in ayurveda

drkspatel2007@yahoo.co.in09427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026